Fatty acids impair endothelium-dependent vasorelaxation: A link between obesity and arterial stiffness in very old zucker rats

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 67 A, Issue 9, 2012, Pages 927-938

  Sloboda, Natacha ^a,b   Fève, Bruno ^a,c,d   Thornton, Simon N ^a,b   Nzietchueng, Rosine ^a,b   Regnault, Véronique ^a,b   Simon, Ginny ^a,b   Labat, Carlos ^a,b   Louis, Huguette ^a,b   Max, Jean Pierre ^a,b   Muscat, Adeline ^a,c   Osborne Pellegrin, Mary ^a,e   Lacolley, Patrick ^a,b   Benetos, Athanase ^a,b,f  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f CHU NANCY BRABOIS   (France)

Author keywords

Aging; Arterial stiffness; Free fatty acids; Obesity; Vascular reactivity

Indexed keywords

ANIMALIA; RATTUS;

AUTACOID; BIOLOGICAL MARKER; CCL2 PROTEIN, RAT; FATTY ACID; MONOCYTE CHEMOTACTIC PROTEIN 1;

AGING; ANIMAL; ARTERIAL STIFFNESS; ARTICLE; BLOOD; CAROTID ARTERY; MALE; OBESITY; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; VASODILATATION; ZUCKER RAT;

AGING; ANIMALS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CHEMOKINE CCL2; FATTY ACIDS, NONESTERIFIED; INFLAMMATION MEDIATORS; MALE; OBESITY; OXIDATIVE STRESS; RATS; RATS, ZUCKER; SIGNAL TRANSDUCTION; VASCULAR STIFFNESS; VASODILATION;

EID: 84865718175     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glr236     Document Type: Article

References (65)

1. International Diabetes Federation. The IDF Consensus Worldwide Defi nition of the Metabolic Syndrome. Brussels, Belgium: International Diabetes Federation; 2006.
2. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004; 27 (10): 2444-2449.
3. McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis. 2011; 12 (5): 333-340.
4. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 2004; 59: 207-223.
5. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24 (4): 683-689.
6. Perreault L, Bergman BC, Playdon MC, Dalla Man C, Cobelli C, Eckel RH. Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? Am J Physiol Endocrinol Metab. 2008; 295 (2): E428-E435.
7. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007; 132 (6): 2087-2102.
8. Gallagher EJ, Leroith D, Karnieli E. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med. 2010; 77 (5): 511-523.
9. Boos CJ, Lip GY. Is hypertension an infl ammatory process? Curr Pharm Des. 2006; 12 (13): 1623-1635.
10. Van Zwieten PA, Kam KL, Pijl AJ, Hendriks MG, Beenen OH, Pfaffendorf M. Hypertensive diabetic rats in pharmacological studies. Pharmacol Res. 1996; 33 (2): 95-105.
11. Phillips MS, Liu Q, Hammond HA, et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet. 1996; 13 (1): 18-19.
12. Louis H, Kakou A, Regnault V, et al. Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol. 2007; 293 (4): H2597-H2604.
13. Huang W, Alhenc Gelas F, Osborne-Pellegrin MJ. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat. Circ Res. 1998; 82 (8): 879-890.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28 (7): 412-419.
15. Agouni A, Lagrue-Lak-Hal AH, Mostefai HA, et al. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One. 2009; 4 (5): e5557.
16. Bu DX, Johansson ME, Ren J, et al. Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair. Arterioscler Thromb Vasc Biol. 2010; 30 (12): 2604-2610.
17. Mendoza-Nunez VM, Rosado-Perez J, Santiago-Osorio E, Ortiz R, Sanchez-Rodriguez MA, Galvan-Duarte RE. Aging linked to type 2 diabetes increases oxidative stress and chronic infl ammation. Rejuvenation Res. 2011; 14 (1): 25-31.
18. Lundman P, Tornvall P, Nilsson L, Pernow J. A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis. 2001; 159 (1): 35-41.
19. Edirisinghe I, McCormick Hallam K, Kappagoda CT. Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta. Clin Sci (Lond). 2006; 111 (2): 145-151.
20. Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000; 49 (11): 1939-1945.
21. Schauer IE, Reusch JE. Nonesterifi ed fatty acid exposure activates protective and mitogenic pathways in vascular smooth muscle cells by alternate signaling pathways. Metabolism. 2009; 58 (3): 319-327.
22. Jiang H, Liang C, Liu X, et al. Palmitic acid promotes endothelial progenitor cells apoptosis via p38 and JNK mitogen-activated protein kinase pathways. Atherosclerosis. 2010; 210 (1): 71-77.
23. Di Nardo F, Burattini R, Cogo CE, Faelli E, Ruggeri P. Age-related analysis of insulin resistance, body weight and arterial pressure in the Zucker fatty rat. Exp Physiol. 2009; 94 (1): 162-168.
24. Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension . 1992; 19 (1 suppl): I110-I115.
25. Galisteo M, Sanchez M, Vera R, et al. A diet supplemented with husks of Plantago ovata reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. J Nutr. 2005; 135 (10): 2399-2404.
26. Subramanian R, MacLeod KM. Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats. Eur J Pharmacol. 2003; 477 (2): 143-152.
27. Mozaffari MS, Abdelsayed R, Liu JY, Wimborne H, El-Remessy A, El-Marakby A. Effects of chromium picolinate on glycemic control and kidney of the obese Zucker rat. Nutr Metab (Lond). 2009; 6: 51.
28. Coimbra TM, Janssen U, Grone HJ, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 2000; 57 (1): 167-182.
29. Johnson PR, Stern JS, Horwitz BA, Harris RE Jr, Greene SF. Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am J Clin Nutr. 1997; 66 (4): 890-903.
30. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity modifi es the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients. Kidney Int. 2011; 79 (7): 765-772.
31. Michel JB, Heudes D, Michel O, et al. Effect of chronic ANG Iconverting enzyme inhibition on aging processes. II. Large arteries. Am J Physiol. 1994; 267 (1 Pt 2): R124-R135.
32. Raveaud S, Mezin P, Lavanchy N, et al. Effects of chronic treatment with a low dose of nicorandil on the function of the rat aorta during ageing. Clin Exp Pharmacol Physiol. 2009; 36 (10): 988-994.
33. Bruel A, Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 1996; 127 (2): 155-165.
34. Labat C, Cunha RS, Challande P, Safar ME, Lacolley P. Respective contribution of age, mean arterial pressure, and body weight on central arterial distensibility in SHR. Am J Physiol Heart Circ Physiol. 2006; 290 (4): H1534-H1539.
35. Zanchi A, Brunner HR, Hayoz D. Age-related changes of the mechanical properties of the carotid artery in spontaneously hypertensive rats. J Hypertens. 1997; 15 (12 Pt 1): 1415-1422.
36. Osborne-Pellegrin M, Labat C, Mercier N, Challande P, Lacolley P. Changes in aortic stiffness related to elastic fi ber network anomalies in the Brown Norway rat during maturation and aging. Am J Physiol Heart Circ Physiol. 2010; 299 (1): H144-H152.
37. Snijder MB, Flyvbjerg A, Stehouwer CD, et al. Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study. Eur J Endocrinol. 2009; 160 (3): 387-395.
38. Safar ME, Thomas F, Blacher J, et al. Metabolic syndrome and agerelated progression of aortic stiffness. J Am Coll Cardiol. 2006; 47 (1): 72-75.
39. Dobrin P. Vascular mechanics. In: Society AP, ed. Handbook of Physiology; vol 3.2: The Cardiovascular System. Baltimore, MD: American Physiology Society; 1983: 65-102.
40. Cox RH. Basis for the altered arterial wall mechanics in the spontaneously hypertensive rat. Hypertension. 1981; 3 (4): 485-495.
41. Bezie Y, Lamaziere JM, Laurent S, et al. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1998; 18 (7): 1027-1034.
42. Sista AK, O'Connell MK, Hinohara T, et al. Increased aortic stiffness in the insulin-resistant Zucker fa/fa rat. Am J Physiol Heart Circ Physiol. 2005; 289 (2): H845-H851.
43. Lacolley P, Boutouyrie P, Glukhova M, et al. Disruption of the elastin gene in adult Williams syndrome is accompanied by a paradoxical reduction in arterial stiffness. Clin Sci (Lond). 2002; 103 (1): 21-29.
44. Lacolley P, Safar ME, Regnault V, Frohlich ED. Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension. Am J Physiol Heart Circ Physiol. 2009; 297 (5): H1567-H1575.
45. Harker CT, O'Donnell MP, Kasiske BL, Keane WF, Katz SA. The renin-angiotensin system in the type II diabetic obese Zucker rat. J Am Soc Nephrol. 1993; 4 (6): 1354-1361.
46. Cox RH, Kikta DC. Age-related changes in thoracic aorta of obese Zucker rats. Am J Physiol. 1992; 262 (5 Pt 2): H1548-H1556.
47. Walker AB, Chattington PD, Buckingham RE, Williams G. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes. 1999; 48 (7): 1448-1453.
48. Yang AL, Chao JI, Lee SD. Altered insulin-mediated and insulin-like growth factor-1-mediated vasorelaxation in aortas of obese Zucker rats. Int J Obes (Lond). 2007; 31 (1): 72-77.
49. Bouvet C, Belin de Chantemele E, Guihot AL, et al. Flow-induced remodeling in resistance arteries from obese Zucker rats is associated with endothelial dysfunction. Hypertension. 2007; 50 (1): 248-254.
50. Vessieres E, Belin de Chantemele EJ, Toutain B, et al. Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese Zucker rat mesenteric arteries. Front Physiol. 2010; 1: 145.
51. Koh KK, Oh PC, Quon MJ. Does reversal of oxidative stress and infl ammation provide vascular protection? Cardiovasc Res. 2009; 81 (4): 649-659.
52. Lee S, Park Y, Dellsperger KC, Zhang C. Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 2011; 301 (2): H306-H314.
53. Oana F, Takeda H, Hayakawa K, et al. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Metabolism. 2005; 54 (8): 995-1001.
54. Szocs Z, Brunmair B, Stadlbauer K, et al. Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats. J Pharmacol Exp Ther. 2008; 326 (1): 323-329.
55. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 2002; 51 (7): 2005-2011.
56. Gao Z, Zhang X, Zuberi A, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol. 2004; 18 (8): 2024-2034.
57. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116 (11): 3015-3025.
58. Boden G, She P, Mozzoli M, et al. Free fatty acids produce insulin resistance and activate the proinfl ammatory nuclear factor-kappaB pathway in rat liver. Diabetes. 2005; 54 (12): 3458-3465.
59. Newens KJ, Thompson AK, Jackson KG, Wright J, Williams CM. Acute effects of elevated NEFA on vascular function: a comparison of SFA and MUFA. Br J Nutr. 2011; 105 (9): 1343-1351.
60. Conway B, Evans RW, Fried L, Kelsey S, Edmundowicz D, Orchard TJ. Free fatty acids are associated with pulse pressure in women, but not men, with type 1 diabetes mellitus. Metabolism. 2009; 58 (9): 1215-1221.
61. Yamazaki K, Hamazaki T, Yano S, Funada T, Ibuki F. Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester. Am J Clin Nutr. 1991; 53 (3): 620-627.
62. Grekin RJ, Dumont CJ, Vollmer AP, Watts SW, Webb RC. Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion. Am J Physiol. 1997; 273 (1 Pt 2): R324-R330.
63. Egan BM, Schork NJ, Weder AB. Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses. Am J Hypertens. 1989; 2 (6 Pt 1): 428-434.
64. Stepniakowski KT, Goodfriend TL, Egan BM. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension. 1995; 25 (4 Pt 2): 774-778.
65. Gao D, Nong S, Huang X, et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem. 2010; 285 (39): 29965-29973.